Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer

被引:0
|
作者
Eun Kyoung Jeon
Hye-Sung Won
Yoon-Ho Ko
In Seok Lee
Tae Ho Hong
Young Kyoung You
Myung Ah Lee
机构
[1] Seoul St. Mary’s Hospital,Division of Oncology, Department of Internal Medicine
[2] Catholic University,Division of Oncology, Department of Internal Medicine
[3] Uijeongbu St. Mary’s Hospital,Division of Gastroenterology, Department of Internal Medicine
[4] Catholic University,Department of Surgery
[5] Seoul St. Mary’s Hospital,undefined
[6] Catholic University,undefined
[7] Seoul St. Mary’s Hospital,undefined
[8] Catholic University,undefined
关键词
Pancreatic cancer; Gemcitabine; Erlotinib; Capecitabine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1625 / 1630
页数:5
相关论文
共 50 条
  • [31] Gemcitabine plus capecitabine is effective in advanced pancreatic cancer
    Nature Clinical Practice Oncology, 2007, 4 (9): : 504 - 504
  • [32] Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Crane, CH
    Janjan, NA
    Evans, DB
    Wolff, RA
    Ballo, MT
    Milas, L
    Mason, K
    Charnsangavej, C
    Pisters, PWT
    Lee, JE
    Lenzi, R
    Vauthey, JN
    Wong, A
    Phan, T
    Nguyen, Q
    Abbruzzese, JL
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 9 - 18
  • [33] A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
    Kortmansky, JS
    O'Reilly, EM
    Minsky, BD
    Puleio, SA
    Winkelmann, J
    Kelsen, DP
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [34] Radiotherapy with concomitant weekly gemcitabine for unresectable pancreatic cancer
    Kawaguchi, A. K.
    Uchida, N.
    Yamamoto, N.
    Notani, M.
    Yokokawa, M.
    Kamiyama, K.
    Yano, S.
    Kitagaki, H.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S303 - S304
  • [35] Combination of gemcitabine & cisplatin chemotherapy in unresectable pancreatic cancer
    Paul, Champklata
    Gupta, P.
    Chitalkar, P. G.
    Sen, A.
    Sarkar, S.
    Sultania, N.
    Mukhopadhyay, S.
    Mukhopadhyay, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 199 - 199
  • [36] Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer: Analysis of toxicity
    Murphy, J. D.
    Normolle, D.
    Adusumilli, S.
    Ten Haken, R. K.
    Ray, M. E.
    Vineberg, K.
    Lawrence, T. S.
    Zalupski, M.
    Ben-Josef, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S265 - S266
  • [37] Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial
    Tomislav Dragovich
    Mark Huberman
    Daniel D. Von Hoff
    Eric K. Rowinsky
    Paul Nadler
    Debra Wood
    Marta Hamilton
    George Hage
    Julie Wolf
    Amita Patnaik
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 295 - 303
  • [38] Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial
    Dragovich, Tomislav
    Huberman, Mark
    Von Hov, Daniel D.
    Rowinsky, Eric K.
    Nadler, Paul
    Wood, Debra
    Hamilton, Marta
    Hage, George
    Wolf, Julie
    Patnaik, Amita
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 295 - 303
  • [39] Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    C. H. Crane
    N. A. Janjan
    D. B. Evans
    R. A. Wolff
    M. T. Ballo
    L. Milas
    K. Mason
    C. Charnsangavej
    P. W. T. Pisters
    J. E. Lee
    R. Lenzi
    J. N. Vauthey
    A. Wong
    T. Phan
    Q. Nguyen
    J. L. Abbruzzese
    International Journal of Pancreatology, 2001, 29 : 9 - 18
  • [40] The efficacy of single capecitabine as second-line treatment for gemcitabine refractory pancreatic Cancer
    Kyun, Jeong Jae
    Mi, Ro Sang
    Ah, Lee Myung
    ANNALS OF ONCOLOGY, 2017, 28